T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse

Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, D. L. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183: 1561

Tisch, R., R. S. Liblau, X. D. Yang, P. Liblau, H. O. McDevitt. 1998. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47: 894

Muir, A., A. Peck, M. Clare-Salzler, Y. H. Song, J. Cornelius, R. Luchetta, J. Krischer, N. Maclaren. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95: 628

Daniel, D., R. G. Gill, N. Schloot, D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056

Balasa, B., B. O. Boehm, A. Fortnagel, W. Karges, K. Van Gunst, N. Jung, S. A. Camacho, S. R. Webb, N. Sarvetnick. 2001. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. Clin. Immunol. 99: 241

Bot, A., D. Smith, S. Bot, A. Hughes, T. Wolfe, L. Wang, C. Woods, M. von Herrath. 2001. Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 2950

Urbanek-Ruiz, I., P. J. Ruiz, V. Paragas, H. Garren, L. Steinman, C. G. Fathman. 2001. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clin. Immunol. 100: 164

Weaver, D. J., Jr, B. Liu, R. Tisch. 2001. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 586

Zekzer, D., F. S. Wong, O. Ayalon, I. Millet, M. Altieri, S. Shintani, M. Solimena, R. S. Sherwin. 1998. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101: 68

Elias, D., T. Reshef, O. S. Birk, R. Van der Zee, M. D. Walker, I. R. Cohen. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088

Haskins, K., M. McDuffie. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249: 1433

Elias, D., H. Marcus, T. Reshef, V. Ablamunits, I. R. Cohen. 1995. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein. Eur. J. Immunol. 25: 2851

Birk, O. S., D. C. Douek, D. Elias, K. Takacs, H. Dewchand, S. L. Gur, M. D. Walker, R. Van der Zee, I. R. Cohen, D. M. Altmann. 1996. A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl. Acad. Sci. USA 93: 1032

Bridgett, M., M. Cetkovic-Cvrlje, R. O’Rourke, Y. Shi, S. Narayanswami, J. Lambert, V. Ramiya, S. Baekkeskov, E. H. Leiter. 1998. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic β-cells. Diabetes 47: 1848

French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. [Published erratum appears in 1997 Diabetes 46:924.]. Diabetes 46: 34

Yoon, J. W., C. S. Yoon, H. W. Lim, Q. Q. Huang, Y. Kang, K. H. Pyun, K. Hirasawa, R. S. Sherwin, H. S. Jun. 1999. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284: 1183

Deltour, L., P. Leduque, N. Blume, O. Madsen, P. Dubois, J. Jami, D. Bucchini. 1993. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc. Natl. Acad. Sci. USA 90: 527

Heath, V. L., N. C. Moore, S. M. Parnell, D. W. Mason. 1998. Intrathymic expression of genes involved in organ specific autoimmune disease. J. Autoimmun. 11: 309

Throsby, M., F. Homo-Delarche, D. Chevenne, R. Goya, M. Dardenne, J. M. Pleau. 1998. Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages. Endocrinology 139: 2399

Daniel, D., D. R. Wegmann. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23). Proc. Natl. Acad. Sci. USA 93: 956

Hutchings, P., A. Cooke. 1998. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund’s adjuvant depends on route of administration. J. Autoimmun. 11: 127

Lacy, P. E., M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35

Hartemann, A. H., M. F. Richard, C. Boitard. 1999. Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 116: 225

White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143: 1822

Neimark, J., J. P. Briand. 1993. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept. Res. 6: 219

King, D. S., C. G. Fields, G. B. Fields. 1990. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 36: 255

Wegmann, D. R., M. Norbury-Glaser, D. Daniel. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24: 1853

Kaufman, D. L., R. Tisch, N. Sarvetnick, L. Chatenoud, L. C. Harrison, K. Haskins, A. Quinn, E. Sercarz, B. Singh, M. von Herrath, et al 2001. Report from the First International NOD Mouse T-Cell Workshop and the follow-up mini-workshop. Diabetes 50: 2459

Corper, A. L., T. Stratmann, V. Apostolopoulos, C. A. Scott, K. C. Garcia, A. S. Kang, I. A. Wilson, L. Teyton. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288: 505

Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12: 699

Simone, E., D. Daniel, N. Schloot, P. Gottlieb, S. Babu, E. Kawasaki, D. Wegmann, G. S. Eisenbarth. 1997. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc. Natl. Acad. Sci. USA 94: 2518

Chao, C. C., H. K. Sytwu, E. L. Chen, J. Toma, H. O. McDevitt. 1999. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. [Published erratum appears in 1999 Proc. Natl. Acad. Sci. USA 96:12970.]. Proc. Natl. Acad. Sci. USA 96: 9299

Herman, A. E., R. M. Tisch, S. D. Patel, S. L. Parry, J. Olson, J. A. Noble, A. P. Cope, B. Cox, M. Congia, H. O. McDevitt. 1999. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J. Immunol. 163: 6275

Haskins, K., D. Wegmann. 1996. Diabetogenic T-cell clones. Diabetes 45: 1299

Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72

Boitard, C., M. C. Villa, C. Becourt, H. P. Gia, C. Huc, P. Sempe, M. M. Portier, J. F. Bach. 1992. Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc. Natl. Acad. Sci. USA 89: 172

Kudva, Y. C., Y. J. Deng, R. Govindarajan, R. S. Abraham, E. V. Marietta, A. L. Notkins, C. S. David. 2001. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Hum. Immunol. 62: 1099

Trembleau, S., G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, L. Adorini. 2000. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J. Immunol. 165: 6748

Karges, W., D. Hammond-McKibben, R. Gaedigk, N. Shibuya, R. Cheung, H. M. Dosch. 1997. Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes 46: 1548

Tree, T. I., D. O’Byrne, J. M. Tremble, W. M. MacFarlane, K. Haskins, R. F. James, K. Docherty, J. C. Hutton, J. P. Banga. 2000. Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients. Clin. Exp. Immunol. 121: 100

Chen, W., I. Bergerot, J. F. Elliott, L. C. Harrison, N. Abiru, G. S. Eisenbarth, T. L. Delovitch. 2001. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J. Immunol. 167: 4926

Tian, J., S. Gregori, L. Adorini, D. L. Kaufman. 2001. The frequency of high avidity T cells determines the hierarchy of determinant spreading. J. Immunol. 166: 7144

Sevilla, N., D. Homann, M. von Herrath, F. Rodriguez, S. Harkins, J. L. Whitton, M. B. Oldstone. 2000. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J. Virol. 74: 3284

von Herrath, M. G., J. Dockter, M. B. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1: 231

Glimcher, L. H., J. A. Schroer, C. Chan, E. M. Shevach. 1983. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J. Immunol. 131: 2868

Rouas, N., S. Christophe, F. Housseau, D. Bellet, J. G. Guillet, J. M. Bidart. 1993. Influence of protein-quaternary structure on antigen processing. J. Immunol. 150: 782